Nanochon Advances Chondrograft Into Human Clinical Study
Panamá City, Panamá, August 14, 2026 Nanochon, Inc., a medical device company developing regenerative solutions for cartilage repair, announced...
FDA Breakthrough Device
Advertisement
Leica Biosystems Expands FDA-Cleared Digital Pathology
Vista, California, August,11, 2026 Leica Biosystems, a Danaher company and global provider of anatomic and digital pathology solutions, has...
Zepto Life Technology Wins NIAID Contract for FungiFlex
St. Paul, Minnesota, August,11, 2026 Zepto Life Technology has been awarded a contract valued at up to $8.9 million...
IceCure Medical Expands ChoICE Study for Breast Cancer
Caesarea, Israel, August 7, 2026 IceCure Medical has announced a significant expansion of its U.S. post-marketing clinical program with...
Ractigen Advances Phase II Trial of RAG-17 for SOD1-ALS
Nantong, China, August 7, 2026 Ractigen Therapeutics has announced a significant milestone in the development of its investigational RNA...
Advertisements
Reckitt Secures FDA Approval for New Mucinex 12HR Therapy
Nutley, New Jersey, USA, August 5, 2026 Reckitt has received U.S. Food and Drug Administration (FDA) approval for Mucinex®...
Medtronic Expands CE Mark for Sphere-9 in Ventricular Ablation
Galway, Ireland, August 6, 2026 Medtronic has secured an expanded CE Mark indication for its Affera™ Mapping and Ablation...
Lilly’s Olomorasib Earns FDA Breakthrough Therapy Designation
Indianapolis, August 3, 2026 Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted...
Fresenius Kabi Gains FDA Approval for Rituximab Biosimilar
Bad Homburg, Germany, August 3, 2026 Fresenius Kabi, an operating company of Fresenius, announced that the U.S. Food and...
Invenio Imaging Completes Enrollment in AI Lung Cancer Study
San Jose, California, August 3, 2026 Invenio Imaging announced the completion of patient enrollment in the ON-SITE pivotal study,...
Advertisement
